Zobrazeno 1 - 10 of 232 pro vyhledávání: '"R. Kruitwagen"'
1
What do we need to know about anatomy in gynaecology
Autor: R. Kruitwagen, Charlotte P. R. Triepels, Dorothea M. Koppes, Toon Van Gorp, Kim J. B. Notten, Fedde Scheele, Annelieke N. Schepens-Franke
Publikováno v: Koppes, D M, Triepels, C P R, Schepens-Franke, A N, Kruitwagen, R F P M, Van Gorp, T, Scheele, F & Notten, K J B 2020, ' What do we need to know about anatomy in gynaecology : A Delphi consensus study ', European Journal of Obstetrics and Gynecology and Reproductive Biology, vol. 245, pp. 56-63 . https://doi.org/10.1016/j.ejogrb.2019.11.015
European Journal of Obstetrics and Gynecology and Reproductive Biology, 245, 56-63. Elsevier Ireland Ltd
European Journal of Obstetrics & Gynecology and Reproductive Biology, 245, pp. 56-63
European Journal of Obstetrics & Gynecology and Reproductive Biology, 245, 56-63
European Journal of Obstetrics & Gynecology and Reproductive Biology, 245, 56-63. Elsevier
Contains fulltext : 225410.pdf (Publisher’s version ) (Closed access) Objective: Determination of the anatomical structures that should be taught to ensure safe and competent practice among general gynaecologists. Study Design: A two-round Delphi s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a97fdb353d1a47ed16c8534164d7ecca
https://doi.org/10.1016/j.ejogrb.2019.11.015
Zobrazit plný text záznamu
4
The role of multimodal adjuvant therapy for FIGO I-II carcinosarcoma of the uterus: a systematic review
Autor: R L, van der Horst, O, van der Hel, L, Lutgens, M, van der Aa, B, Slangen, R, Kruitwagen, R I, Lalisang
Publikováno v: Critical Reviews in Oncology/Hematology. 175:103701
The uterine carcinosarcoma (UCS) is a rare entity with poor prognosis. Treatment of FIGO I-II UCS usually consists of surgery with or without adjuvant treatment. Due to the high metastatic potential, aggressive combined modality adjuvant treatment ap
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a10dcb8acec7f32ce2eb3053da0cbca7
https://doi.org/10.1016/j.critrevonc.2022.103701
Zobrazit plný text záznamu
6
Incomplete surgical staging in clinical early-stage ovarian cancer: guidelines versus daily practice
Autor: M. Van Der Aa, MC Vos, T Van Gorp, D. Boll, J B Trimbos, N. Reesink, J E Bense, Hgj Arts, P Laven, J.J. Beltman, R Kruitwagen
Publikováno v: Surgery Open Science
Surgery Open Science, 7, 6-11. Elsevier BV
Surgery Open Science, Vol 7, Iss, Pp 6-11 (2022)
Surgery open science, 7, 6-11. Elsevier
BACKGROUND: Incomplete surgical staging of patients with early-stage epithelial ovarian cancer (EOC) has been reported in up to 98% of cases, when based on the International Federation of Obstetrics and Gynecology (FIGO) staging procedure. The aim of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e7fcf3bd6342d266ff5d66424d63987
https://pubmed.ncbi.nlm.nih.gov/34778737
Zobrazit plný text záznamu
7
Postoperative outcomes of primary and interval cytoreductive surgery for advanced ovarian cancer registered in the Dutch Gynecological Oncology Audit (DGOA)
Autor: MC Vos, H.T.C. Nagel, R.A. Smit, N. Reesink, A. Baalbergen, Eva Maria Roes, P.J. Timmers, Arnold-Jan Kruse, Jan Willem M. Mens, Mirjam J. A. Engelen, B.A.J.T. Visschers, T.C. Stam, H.P.M. Smedts, N.M.S. Baldewpersad Tewarie, A. van der Kolk, J. Lange, H. Verhoeve, Katja N. Gaarenstroom, Michel W.J.M. Wouters, Brigitte F. M. Slangen, I. Ebisch, Sjors F.P.J. Coppus, D. Boll, L. Hofman, C. G. Gerestein, Y.W.C.M. van der Plas-Koning, J. de Waard, A.M.L.D. van Haaften-de Jong, E.B.L. van Dorst, J. Diepstraten, A.D. Ten Cate, M.Y. Tjiong, M.A. van der Aa, R. Yigit, A.L. Aalders, R Kruitwagen, J. Briet, W.J. van Driel, M. van Ham, P.M.L.H. Vencken, M.B. Verbruggen, M. Huisman, Guus Fons
Publikováno v: Gynecologic Oncology, 162(2), 331-338. Elsevier Science
Gynecologic Oncology, 162, 2, pp. 331-338
Gynecologic Oncology, 162, 331-338
On behalf of the participants of the Dutch Gynecological Oncology Collaborator Group 2021, ' Postoperative outcomes of primary and interval cytoreductive surgery for advanced ovarian cancer registered in the Dutch Gynecological Oncology Audit (DGOA) ', Gynecologic Oncology, vol. 162, no. 2, pp. 331-338 . https://doi.org/10.1016/j.ygyno.2021.05.030
Gynecologic oncology, 162(2), 331-338. Academic Press Inc.
Gynecologic Oncology, 162(2), 331-338. Academic Press Inc.
Gynecologic Oncology, 162(2), 331-338. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 162(2), 331-338. Academic Press
Objectives. The challenge when performing cytoreductive surgery (CRS) is to balance the benefits and risks. The aim of this study was to report short term postoperative morbidity and mortality in relation to surgical outcome in patients undergoing pr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ea3ca6a5e9699a01b8fa682b8f2669f
https://doi.org/10.1016/j.ygyno.2021.05.030
Zobrazit plný text záznamu
8
42 Clinicopathologic predictors of early relapse in advanced epithelial ovarian cancer; development of prediction models using nationwide data
Autor: AM van Altena, S Said, Sabine Siesling, J.A. de Hullu, Gabe S. Sonke, M. Van Der Aa, R. Bretveld, R Kruitwagen, Hendrik Koffijberg
Publikováno v: Oral Poster – TAPED.
Objective To identify clinicopathologic factors predictive of early relapse (i.e. a platinum-free interval (PFI) of ≤6 months) in advanced epithelial ovarian cancer (EOC) in first-line treatment, and to develop and internally validate risk predicti
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ad17fa291259592d1ba6974b5331b8d2
https://doi.org/10.1136/ijgc-2020-igcs.42
Zobrazit plný text záznamu
9
87 Sentinel lymph node identification in early stage ovarian cancer: is it still possible after prior tumor resection?
Autor: P Laven, S Lambrechts, R Kruitwagen
Publikováno v: Poster.
Objective Sentinel lymph node (SLN) detection in ovarian cancer is feasible when tracers are injected before the pathological ovary is resected. This study aims to investigate whether the SLN identification is also feasible in patients whose ovarian
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2dc12d359bafd37987a3b74a45972698
https://doi.org/10.1136/ijgc-2020-igcs.82
Zobrazit plný text záznamu
10
153 Clinical auditing as an instrument to improve cancer care: the dutch gynaecological oncology audit (DGOA)
Autor: R Kruitwagen, W.J. van Driel, N Tewarie, Michel W.J.M. Wouters
Publikováno v: Poster.
Introduction The Dutch Gynaecological Oncology Audit (DGOA) was initiated in 2013 where all patients with a gynaecological malignancy are registered. The aim of this study is to present the first results of clinical auditing from the DGOA for ovarian
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::47e6395aee4de17f68fe7f2173db7573
https://doi.org/10.1136/ijgc-2020-igcs.132
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje